Symbols

ASTH

Astrana Health·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 1

Consensus Rating "Strong Buy"

EPS Beats Expectation

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About ASTH

Astrana Health, Inc.

A leading physician-centric, technology-powered, risk-bearing healthcare management company

Industry

Healthcare Providers and Services

Established Date

11/01/1985

Listing Date

12/08/2017

Exchange

NASDAQ Stock Exchange

Full-time Employees

3,000

Fiscal Year Ends

12-31

Website

www.astranahealth.com

Security Type

Common stock

Office address

1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801

Business

Introduction

Astrana Health, Inc., was incorporated in Delaware on November 1, 1985. The company is a doctor-centric, technology-driven healthcare company that enables healthcare providers to participate in value-based healthcare arrangements through its all-in-one delivery platform. It operates through three divisions: the Nursing Partners Division, which manages the healthcare provider network, the Care Delivery Division, and the Care Empowerment Division, serving patients under Medicare, Medicaid and commercial insurance plans.

Company Financials

EPS

ASTH has released its 2025 Q4 earnings. EPS was reported at 0.54, versus the expected 0.1, beating expectations. The chart below visualizes how ASTH has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

ASTH has released its 2025 Q4 earnings report, with revenue of 950.53M, reflecting a YoY change of 42.89%, and net profit of 6.56M, showing a YoY change of 184.38%. The Sankey diagram below clearly presents ASTH's revenue sources and cost distribution.